Abstract:Chronic arsenic exposure is a global health hazard significantly associated with the development of deleterious cutaneous changes and increased keratinocyte cancer risk. Although arsenic exposure is associated with broad-scale cellular and molecular changes, gaps exist in understanding how these changes impact the skin and facilitate malignant transformation. Recently developed epigenetic "clocks" can accurately predict chronological, biological and mitotic age, as well as telomere length, on the basis of tissue DNA methylation state. Deviations of predicted from expected age (epigenetic age dysregulation) have been associated with numerous complex diseases, increased all-cause mortality and higher cancer risk. We investigated the ability of these algorithms to detect molecular changes associated with chronic arsenic exposure in the context of associated skin lesions. To accomplish this, we utilized a multi-algorithmic approach incorporating seven "clocks" ( Horvath, Skin&Blood, PhenoAge, PCPhenoAge, GrimAge, DNAmTL and epiTOC2 ) to analyze peripheral blood of pediatric and adult cohorts of arsenic-exposed (n = 84) and arsenic-naïve (n = 33) individuals, among whom n = 18 were affected by skin lesions. Arsenic-exposed adults with skin lesions exhibited accelerated epigenetic ( Skin&Blood : + 7.0 years [95% CI 3.7; 10.2], q = 6.8 × 10 –4 ), biological ( PhenoAge: + 5.8 years [95% CI 0.7; 11.0], q = 7.4 × 10 –2 , p = 2.8 × 10 –2 ) and mitotic age ( epiTOC2: + 19.7 annual cell divisions [95% CI 1.8; 37.7], q = 7.4 × 10 –2 , p = 3.2 × 10 –2 ) compared to healthy arsenic-naïve individuals; and accelerated epigenetic age ( Skin&Blood: + 2.8 years [95% CI 0.2; 5.3], q = 2.4 × 10 –1 , p = 3.4 × 10 –2 ) compared to lesion-free arsenic-exposed individuals. Moreover, lesion-free exposed adults exhibited accelerated Skin&Blood age (+ 4.2 [95% CI 1.3; 7.1], q = 3.8 × 10 –2 ) compared to their arsenic-naïve counterparts. Compared to the pediatric group, arsenic-exposed adults exhibited accelerated epigenetic (+ 3.1 to 4.4 years (95% CI 1.2; 6.4], q = 2.4 × 10 –4 –3.1 × 10 –3 ), biological (+ 7.4 to 7.8 years [95% CI 3.0; 12.1] q = 1.6 × 10 –3 –2.8 × 10 –3 ) and mitotic age (+ 50.0 annual cell divisions [95% CI 15.6; 84.5], q = 7.8 × 10 –3 ), as well as shortened telomere length (− 0.23 kilobases [95% CI − 0.13; − 0.33], q = 2.4 × 10 –4 ), across all seven algorithms. We demonstrate that lifetime arsenic exposure and presence of arsenic-associated skin lesions are associated with accelerated epigenetic, biological and mitotic age, and shortened telomere length, reflecting altered immune signaling and genomic regulation. Our findings highlight the usefulness of DNA methylation-based algorithms in identifying deleterious molecular changes associated with chronic exposure to the heavy metal, serving as potential prognosticators of arsenic-induced cutaneous malignancy.

Arsenic Exposure and Epigenetic Aging: The Association with Cardiovascular Disease and All-Cause Mortality in the Strong Heart Study

Arsenic Exposure, Blood DNA Methylation, and Cardiovascular Disease

Roles of Serum Uric Acid on the Association Between Arsenic Exposure and Incident Metabolic Syndrome in an Older Chinese Population

The impact of prenatal and early-life arsenic exposure on epigenetic age acceleration among adults in Northern Chile

Marking Time: Epigenetic Aging May Partially Explain the Arsenic-Cardiovascular Disease Link

Cardiovascular adverse effects and mechanistic insights of arsenic exposure: a review

Signatures of epigenetic, biological and mitotic age acceleration and telomere shortening are associated with arsenic-induced skin lesions

Arsenic exposure from drinking water is associated with decreased gene expression and increased DNA methylation in peripheral blood

Arsenic induced cardiotoxicity: An approach for molecular markers, epigenetic predictors and targets

Synergy of arsenic with smoking in causing cardiovascular disease mortality: A cohort study with 27 follow-up years in China

Effect of an Arsenic Mitigation Program on Arsenic Exposure in American Indian Communities: A Cluster Randomized Controlled Trial of the Community-Led Strong Heart Water Study Program

Arsenic, blood pressure, and hypertension in the Strong Heart Family Study

Arsenite exposure accelerates aging process regulated by the transcription factor DAF-16/FOXO in Caenorhabditis elegans

Epigenetic Clocks And Incident Heart Failure: The Atherosclerosis Risk In Communities

Arsenic induces metabolome remodeling in mature human adipocytes

Exposure to arsenic at different life-stages and DNA methylation meta-analysis in buccal cells and leukocytes

Arsenic-gene interactions and beta-cell function in the Strong Heart Family Study

Genome-wide alteration of histone methylation profiles associated with cognitive changes in response to developmental arsenic exposure in mice

Epigenetic mechanisms underlying the toxic effects associated with arsenic exposure and the development of diabetes

Impact of prenatal arsenic exposure on chronic adult diseases

Effects of arsenic exposure on lipid metabolism: a systematic review and meta-analysis